ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 142 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mayo Clinic | 187,143 | $765,415 | 25.27% |
| Decheng Capital LLC | 3,070,442 | $12,558,107 | 3.85% |
| MPM BioImpact LLC | 1,450,000 | $5,930,500 | 0.92% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 961,486 | $3,932,478 | 0.80% |
| Eventide Asset Management | 8,547,896 | $34,960,895 | 0.60% |
| 5AM Venture Management, LLC | 490,000 | $2,004,100 | 0.45% |
| Matrix Capital Management Company, LP | 13,959,973 | $57,096,290 | 0.44% |
| Values First Advisors, Inc. | 74,925 | $306,443 | 0.18% |
| Boxer Capital, LLC | 450,000 | $1,840,500 | 0.10% |
| GSA CAPITAL PARTNERS LLP | 255,201 | $1,044 | 0.07% |
| XTX Topco Ltd | 178,465 | $729,922 | 0.06% |
| Birchview Capital, LP | 16,000 | $65,440 | 0.06% |
| Woodline Partners LP | 1,517,077 | $6,204,845 | 0.06% |
| Carson Advisory Inc. | 15,770 | $64,499 | 0.04% |
| Corton Capital Inc. | 20,185 | $82,557 | 0.04% |
| Pennant Investors, LP | 32,400 | $132,516 | 0.04% |
| FOX RUN MANAGEMENT, L.L.C. | 40,067 | $163,874 | 0.03% |
| SHERBROOKE PARK ADVISERS LLC | 41,339 | $169,077 | 0.03% |
| Virtu Financial LLC | 93,186 | $381 | 0.03% |
| Y-Intercept (Hong Kong) Ltd | 103,916 | $425,016 | 0.02% |
External links
This page lists ZENTALIS PHARMACEUTICALS INC's shareholders in Q2 2024. To view ZENTALIS PHARMACEUTICALS INC's shareholder history, click here.